According to these findings, HMGB1 plays a pivotal role in CAFs-mediated breast cancer progression and chemoresistance, and targeting HMGB1 may be an effective strategy to diminish chemoresistance in breast cancer. This evidence concerns the gene HMGB1 and breast carcinoma.